Literature DB >> 22871356

Quantitative determination of matrix Gla protein (MGP) and BMP-2 during the osteogenic differentiation of human periodontal ligament cells.

Ran Li1, Xianyu Li, Mi Zhou, Nana Han, Qi Zhang.   

Abstract

BACKGROUND AND
OBJECTIVE: Matrix Gla protein (MGP) has been recognized as a potent calcification inhibitor and a regulator for bone morphogenetic protein-2 (BMP-2). The periodontal ligament (PDL) is a non-mineralized connective tissue located between two mineralized tissues, the cementum and the alveolar bone. However, the mechanism by which PDL prevents mineralization has yet to be defined. This study aims to examine the expression pattern of MGP and BMP-2 during human periodontal ligament cells (hPDLCs) osteogenic differentiation in vitro, preliminarily exploring their roles in this process.
MATERIALS AND METHODS: hPDLCs were obtained and cultured in mineralizing medium. The expression of MGP and BMP-2 was confirmed by RT-PCR and immunofluorescence staining. In the process of osteogenic induction, alkaline phosphatase (ALP) activity, extracelluar calcium deposition, and mineralized nodules were measured. Quantitative real-time RT-PCR was performed to evaluate mRNA expression of MGP, BMP-2 and osteogenic marker genes, including ALP, bone sialoprotein (BSP), type I collagen (COLI), osteocalcin (OCN), and runt-related transcription factor 2 (Runx2). The protein expression of MGP and BMP-2 was analyzed by western blotting.
RESULTS: Co-localization of MGP and BMP-2 was visualized in hPDLCs. After osteogenic induction, ALP activity, calcium deposition, mineralized nodules, and osteogenic marker genes were significantly up-regulated. mRNA expression of MGP and BMP-2 generally decreased, although MGP mRNA increased on day 14 and 21 compared with the control, and protein expression of MGP and BMP-2 was down-regulated.
CONCLUSION: Our results indicate that MGP might regulate hPDLCs osteogenic differentiation which might keep a potential relationship with BMP-2 in this process.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871356     DOI: 10.1016/j.archoralbio.2012.07.005

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  6 in total

1.  HtrA1 may regulate the osteogenic differentiation of human periodontal ligament cells by TGF-β1.

Authors:  Ran Li; Qi Zhang
Journal:  J Mol Histol       Date:  2015-03-01       Impact factor: 2.611

2.  Aberrantly elevated Wnt signaling is responsible for cementum overgrowth and dental ankylosis.

Authors:  Yan Wu; Xue Yuan; Kristy C Perez; Sydnee Hyman; Liao Wang; Gretel Pellegrini; Benjamin Salmon; Teresita Bellido; Jill A Helms
Journal:  Bone       Date:  2018-10-25       Impact factor: 4.398

3.  RNA-Seq Expression Analysis of Enteric Neuron Cells with Rotenone Treatment and Prediction of Regulated Pathways.

Authors:  Qiang Guan; Xijin Wang; Yanyan Jiang; Lijuan Zhao; Zhiyu Nie; Lingjing Jin
Journal:  Neurochem Res       Date:  2016-11-30       Impact factor: 3.996

4.  Matrix Gla Protein Promotes the Bone Formation by Up-Regulating Wnt/β-Catenin Signaling Pathway.

Authors:  Jie Zhang; Zhenrong Ma; Kang Yan; Yong Wang; Ya Yang; Xiang Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-20       Impact factor: 5.555

5.  Intermittent Hypoxia Influences Alveolar Bone Proper Microstructure via Hypoxia-Inducible Factor and VEGF Expression in Periodontal Ligaments of Growing Rats.

Authors:  Shuji Oishi; Yasuhiro Shimizu; Jun Hosomichi; Yoichiro Kuma; Hideyuki Maeda; Hisashi Nagai; Risa Usumi-Fujita; Sawa Kaneko; Naoki Shibutani; Jun-Ichi Suzuki; Ken-Ichi Yoshida; Takashi Ono
Journal:  Front Physiol       Date:  2016-09-16       Impact factor: 4.566

6.  Profiling the miRNA-mRNA-lncRNA interaction network in MSC osteoblast differentiation induced by (+)-cholesten-3-one.

Authors:  Qiuke Hou; Yongquan Huang; Yamei Liu; Yiwen Luo; Bin Wang; Rudong Deng; Saixia Zhang; Fengbin Liu; Dongfeng Chen
Journal:  BMC Genomics       Date:  2018-10-29       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.